News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Andrea Necchi: Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI
Dec 25, 2024, 14:47

Andrea Necchi: Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI

Andrea Necchi, Associate Editor of the Journal of Clinical Oncology, shared a recent article on X:

“Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI in Radiology.”

Title: Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI

Authors: Giorgio Brembilla , Giuseppe Basile, Michele Cosenza, Francesco Giganti, Andrea Del Prete, Tommaso Russo, Renato Pennella, Salvatore Lavalle, Daniele Raggi, Chiara Mercinelli, Valentina Tateo, Antonio Cigliola, Damiano Patanè, Emanuele Crupi, Patrizia Giannatempo, Antonella Messina, Giuseppina Calareso, Alberto Martini, Marco Bandini, Marco Moschini, Gianpiero Cardone, Alberto Briganti, Francesco Montorsi, Andrea Necchi and Francesco De Cobelli

Andrea Necchi

“Are you searching for the largest study on VIRADS?

Here is the Christmas gift from Giorgio Brembilla.”

More posts featuring Andrea Necchi.

Andrea Del Prete Andrea Necchi bladder cancer cancer chemotherapy Francesco De Cobelli Francesco Giganti Giorgio Brembilla Giuseppe Basile immunotherapy Michele Cosenza MRI OncoDaily Oncology Radiology
Special Coverage
Drugs
Apr 25, 2025, 05:55
Durvalumab (Imfinzi): What patients need to know?
Blog
Apr 25, 2025, 05:27
Applications are still open for The SIOG Advanced Course 2025
Career
Apr 25, 2025, 04:25
Cary Adams endorses Dato' Dr Saunthari Somasundaram as the candidate for the President-elect for the NCD Alliance
Oncolibrary
Apr 25, 2025, 02:46
FDA Approves Penpulimab for Recurrent or Metastatic Non-Keratinizing Nasopharyngeal Carcinoma
Career
Apr 24, 2025, 21:39
Triparna Sen: I am thrilled and humbled to be nominated as a candidate for the IASLC Board of Directors
Blog
Apr 24, 2025, 21:05
Liz O’Riordan: 25 things I wish I had known before I got breast cancer
Blog
Apr 24, 2025, 20:53
Signing Ceremony of MoU Between Doha University for Science and Technology and Qatar Cancer Society
Blog
Apr 24, 2025, 20:40
Yan Leyfman: How AI is transforming cancer care - from improving diagnosis to reducing disparities
Insight
Apr 24, 2025, 20:28
Fernando Campos: We revealed a harsh Brazilian reality in Sarcoma Study
Insight
Apr 24, 2025, 19:38
George Vlachogiannis: Black patients were less likely to receive nephrectomy compared to non-Hispanic White patients
Blog
Apr 24, 2025, 18:30
Paolo Tarantino: Recent ADCs took a median time of 7 years from clinical introduction to approval
Blog
Apr 24, 2025, 17:56
Milestones from Philippine Cervical Cancer Elimination Operational Plan Workshop - APAC Women's Cancer Coalition